Millendo Therapeutics Inc (MLND)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS

110 MILLER AVENUE, SUITE 100 ANN ARBOR, MI 48104

OvaScience, Inc., a life science company, focuses on the discovery, development, and commercialization of proprietary products to improve the treatment of female infertility. The companys patented technology is based on the discovery of egg precursor cells, which are found in the ovaries.

Data as of 2021-05-08 11:17:18 -0400
Market Cap20.757 Million Shares Outstanding19.043 Million Avg 30-day Volume1.506 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.86 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.31946 52-week High/Low3.64 / 0.9181 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from MLND instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 42 46 -8.7% 16 (0.96%) 18 (1.12%) -11.11%
13F shares: 7.68 Million 7.91 Million -2.91% 4.441 Million 4.473 Million -0.73%
% Ownership 40.421 41.6304 -2.91% 23.3719 23.5441 -0.73%
New Positions: 5 5 0.0% 3 4 -25.0%
Increased Positions 12 7 71.43% 6 1 500.0%
Closed Positions 9 15 -40.0% 5 4 25.0%
Reduced Positions 13 21 -38.1% 4 10 -60.0%
Total Calls 23.1 Thousand 28.2 Thousand -18.09% 0
Total Puts 0 32.7 Thousand -100.0% 0 16.3 Thousand -100.0%
PUT/CALL Ratio 0.0 1.16 -100.0% -100.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MLND (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MLND BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

OWENS JULIA C. EXECUTIVE CHAIR

  • Officer
  • Director
24,000 2021-03-17 2

ARCUDI III LOUIS J PRESIDENT AND CEO

  • Officer
  • Director
400,000 2021-02-26 2

MINAI-AZARY JENNIFER LYNN CHIEF FINANCIAL OFFICER

  • Officer
110,000 2021-02-26 2

HOWE JOHN P MD

  • Director
0 2020-06-22 1

DABLE HABIB J

  • Director
0 2020-06-22 1

GALLAGHER CAROL GILTNER

  • Director
0 2020-06-22 1

HEDLEY MARY LYNNE

  • Director
0 2020-06-22 1

HINDMAN JAMES M.

  • Director
0 2020-06-22 1

NUECHTERLEIN CAROLE

  • Director
0 2020-06-22 1

NICHOL GEOFFREY

  • Director
0 2020-06-22 1

ZEIDAN RYAN CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-05-25 1

JOSEPH TAMARA L GENERAL COUNSEL AND SECRETARY

  • Officer
0 2020-05-25 1

ARBET-ENGELS CHRISTOPHE CHIEF MEDICAL OFFICER

  • Officer
0 2020-05-25 1

WHITCOMB RANDALL W

  • Director
0 2019-06-20 0

BRINZA JEFFERY M. SEC., CAO AND GENERAL COUNSEL

  • Officer
0 2019-01-15 0

MOHIDEEN PHARIS CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-15 0

ALDRICH RICHARD

  • Director
No longer subject to file 2018-12-07 0

FISHER MARY

  • Director
No longer subject to file 2018-12-07 0

KOZIN MARC D

  • Director
No longer subject to file 2018-12-07 0

GILLIS JONATHAN SENIOR VICE PRESIDENT, FINANCE

  • Officer
No longer subject to file 2018-12-07 0

KROEGER CHRISTOPHER A. CHIEF EXECUTIVE OFFICER

  • Officer
No longer subject to file 2018-12-07 0

LILLIE JAMES WOODRUFF CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2018-12-07 0

FHM VI, L.L.C.

FHM VI, L.P.

FRAZIER HEALTHCARE VI, L.P.

  • 10% Owner
1,396,615 2018-12-07 0

NEW ENTERPRISE ASSOCIATES 15, L.P.

NEA PARTNERS 15, L.P.

NEA 15 GP, LLC

  • 10% Owner
1,766,407 2018-12-07 0

BARRIS PETER J

  • 10% Owner
1,766,407 2018-12-07 0

BASKETT FOREST

  • 10% Owner
1,766,407 2018-12-07 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
1,766,407 2018-12-07 0

MAKHZOUMI MOHAMAD

  • 10% Owner
1,766,407 2018-12-07 0

MAKOWER JOSHUA

  • 10% Owner
1,766,407 2018-12-07 0

MOTT DAVID M

  • 10% Owner
1,766,407 2018-12-07 0

SANDELL SCOTT D

  • 10% Owner
1,766,407 2018-12-07 0

SONSINI PETER W.

  • 10% Owner
1,766,407 2018-12-07 0

CAPELLO JEFFREY D

  • Director
0 2018-07-04 0

SEXTON JOHN

  • Director
0 2018-07-04 0

DIPP MICHELLE EXECUTIVE CHAIR

  • Officer
  • Director
0 2017-06-21 0

MALLEY THOMAS

  • Director
204,981 2017-06-13 0

COUTURIER CHRISTOPHE CHIEF FINANCIAL OFFICER

  • Officer
0 2017-03-02 0

CHAPMAN PAUL W.D. CHIEF OPERATING OFFICER

  • Officer
3,100 2016-05-10 0

STOCK HARALD F.

  • Director
266,422 2016-01-05 0

YOUNG JEFFREY E CHIEF FINANCIAL OFFICER

  • Officer
53,750 2015-12-03 0

TZIANABOS ARTHUR PRESIDENT AND CSO

  • Officer
26,400 2015-12-03 0

MCNEELY THERESA EVP, CHIEF COMM. OFFICER

  • Officer
400 2015-04-08 0

LONGWOOD FUND, L.P.

  • 10% Owner
No longer subject to file 2015-01-14 0

HARDING DAVID CHIEF COMMERCIAL OFFICER

  • Officer
0 2014-12-09 0

LAWTON ALISON FRANCIS CHIEF OPERATING OFFICER

  • Officer
0 2013-03-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

OWENS JULIA C. - Director - Officer EXECUTIVE CHAIR

2021-03-19 16:47:56 -0400 2021-03-17 A 24,000 a 24,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MILLENDO THERAPEUTICS INC MLND 2021-05-10 22:15:04 UTC -2.7031 2.7531 95000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 21:45:02 UTC -2.1146 2.1646 95000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 21:15:02 UTC -2.1146 2.1646 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 20:45:03 UTC -2.0263 2.0763 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 20:15:03 UTC -2.0263 2.0763 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 19:45:03 UTC -2.0263 2.0763 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 19:15:03 UTC -2.0263 2.0763 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 18:45:03 UTC -1.9746 2.0246 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 18:15:03 UTC -1.9746 2.0246 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 17:45:02 UTC -1.9746 2.0246 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 17:15:03 UTC -1.9746 2.0246 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 16:45:03 UTC -2.2524 2.3024 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 16:15:03 UTC -2.2524 2.3024 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 15:45:03 UTC -2.2524 2.3024 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 15:15:03 UTC -2.2524 2.3024 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 14:45:04 UTC -2.3629 2.4129 90000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 14:15:04 UTC -2.3629 2.4129 100000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 13:45:04 UTC -2.3629 2.4129 100000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 13:15:03 UTC -2.3629 2.4129 100000
MILLENDO THERAPEUTICS INC MLND 2021-05-10 12:45:02 UTC -2.3629 2.4129 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments